Tanya Lewis Karyopharm Therapeutics Inc. (KPTI) insider trading activity

KPTI Quotes by TradingView

Tanya Lewis is EVP, Chief Reg. Affairs of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 45,401 shares of KPTI, which is worth approximately $32,688. The most recent transaction as insider was on Feb 25, 2021, when has been sold 22,013 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.4K
0% 3M change
0% 12M change
Total Value Held $32,688

Tanya Lewis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2021
BUY
Grant, award, or other acquisition
-
22,013 Added 32.65%
45,401 Common Stock
Feb 11 2021
SELL
Open market or private sale
$31,754 $15.52 p/Share
2,046 Reduced 33.06%
4,143 Common Stock
Feb 05 2021
BUY
Exercise of conversion of derivative security
-
5,650 Added 47.72%
6,189 Common Stock
Oct 30 2020
SELL
Open market or private sale
$3,521 $15.58 p/Share
226 Reduced 29.54%
539 Common Stock
Oct 28 2020
BUY
Exercise of conversion of derivative security
-
765 Added 50.0%
765 Common Stock

Also insider at

REPL
Replimune Group, Inc. Healthcare
Chief Dev. Op. Officer
DMAC
DiaMedica Therapeutics Inc. Healthcare
Director
TL

Tanya Lewis

EVP, Chief Reg. Affairs
Woburn, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KPTI